The 12-month price targets, analyzed by analysts, offer insights with an average target of $33.0, a high estimate of $40.00, and a low estimate of $24.00. Experiencing a 16.46% decline, the current ...
Morgan Stanley resumed coverage of Helmerich & Payne with an Underweight rating and $27 price target The firm contends that the market may ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback